Metraipolis › archive › dc_fb511d66c173

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41641897
DOI
10.1002/cpdd.70031
License (as archived)
solo-consultazione
Archived
2026-11-06T08:17:50.635Z
SHA-256 of the archived text
6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975
Stable URL of this page
https://metraipolis.com/documento/dc_fb511d66c173

How to cite

Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897 — Europe PMC (en), https://europepmc.org/article/MED/41641897 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fb511d66c173 (Metraipolis archive dc_fb511d66c173, sha256 6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975)
BibTeX
@misc{dcfb511d66c173,
  title = {Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results… — Europe PMC PMID:41641897},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41641897},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fb511d66c173; sha256 6f8c2e3c79755af29376566e64929b76d64d19c0285fcdeccfb42a1164921975},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41641897. Agents can read the archived copy with the MCP tool read_document.